Discounted Cash Flow
Merck & Co., Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $39.8b | $3.9b | $8.8b | 9.8% | $1.42 |
| 2017 | $40.1b (0.8%) | $2.4b (-38.9%) | $4.6b (-48.0%) | 6.0% (-39.4%) | $0.88 (-38.0%) |
| 2018 | $42.3b (5.4%) | $6.2b (159.8%) | $8.3b (82.2%) | 14.7% (146.5%) | $2.34 (165.9%) |
| 2019 | $46.8b (10.7%) | $9.8b (58.2%) | $10.0b (20.0%) | 21.0% (42.9%) | $3.84 (64.1%) |
| 2020 | $48.0b (2.5%) | $7.1b (-28.2%) | $5.6b (-44.1%) | 14.7% (-29.9%) | $2.79 (-27.3%) |
| 2021 | $48.7b (1.5%) | $13.0b (84.6%) | $-3.5b (-162.1%) | 26.8% (82.0%) | $5.16 (84.9%) |
| 2022 | $59.3b (21.7%) | $14.5b (11.3%) | $-4.4b (-26.8%) | 24.5% (-8.6%) | $5.73 (11.0%) |
| 2023 | $60.1b (1.4%) | $365.0m (-97.5%) | $-955.0m (78.2%) | 0.6% (-97.5%) | $0.14 (-97.6%) |
| 2024 | $64.2b (6.7%) | $17.1b (4589.6%) | $20.9b (2293.6%) | 26.7% (4293.4%) | $6.76 (4728.6%) |
| 2025 | $65.0b (1.3%) | $18.3b (6.6%) | $15.3b (-27.1%) | 28.1% (5.3%) | $7.30 (8.0%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.